The aim of this study was, therefore, to investigate the following hypotheses: (1) genetic variations in the TSC22D3 gene are detectable in a cohort of sepsis and control subjects, and (2) the genetic variants detected have an impact on the outcome of sepsis. The gene discussed is TSC22D3; the disease is Sepsis.